Microfluidic integration for automated targeted proteomic assays

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages 5972-5977

  Hughes, Alex J ^a,b   Lin, Robert K C ^a   Peehl, Donna M ^c   Herr, Amy E ^a,b  

^a University of California at Berkeley   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody selection; Isoelectric focusing; Lab on a chip; Nanoporous reactive polymers; Western blotting

Indexed keywords

ISOPROTEIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CELL; CELL LYSATE; ELECTROBLOTTING; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROFLUIDICS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEOMICS;

CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MALE; MICROFLUIDICS; MICROSCOPY, FLUORESCENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859950124     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1108617109     Document Type: Article

References (30)

1. Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM (2010) Antibody-based proteomics: Fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 10:605-617.
2. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat Biotechnol 24:971-983. (Pubitemid 44215392)
3. Zhu CS, et al. (2011) A framework for evaluating biomarkers for early detection: Validation of biomarker panels for ovarian cancer. Cancer Prev Res 4:375-383.
4. Esserman L, Shieh Y, Thompson I (2009) Rethinking screening for breast cancer and prostate cancer. JAMA 302:1685-1692.
5. Etzioni R, et al. (2003) The case for early detection. Nat Rev Cancer 3:243-252. (Pubitemid 37328860)
6. Jung K, et al. (2004) Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: Potential to improve diagnosis of prostate cancer. Clin Chem 50:2292-2301. (Pubitemid 39552164)
7. Sarrats A, et al. (2010) Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis. Prostate 70:1-9.
8. Tabares G, et al. (2005) Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 16:132-145. (Pubitemid 43125969)
9. Kyselova Z, et al. (2007) Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6:1822-1832. (Pubitemid 46814506)
10. Gaster RS, et al. (2009) Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat Med 15:1327-1333.
11. Rissin DM, et al. (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28:595-600.
12. Vickers AJ, et al. (2008) A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: Data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden. BMC Med 6:19-28.
13. Zolg W (2006) The proteomic search for diagnostic biomarkers: Lost in translation? Mol Cell Proteomics 5:1720-1726.
14. He M, Herr AE (2010) Automated microfluidic protein immunoblotting. Nat Protoc 5:1844-1856.
15. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7:148-155.
16. Anderson GJ, Cipolla CM, Kennedy RT (2011) Western blotting using capillary electrophoresis. Anal Chem 83:1350-1355.
17. O'Neill RA, et al. (2006) Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci USA 103:16153-16158. (Pubitemid 44717502)
18. Fan AC, et al. (2009) Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat Med 15:566-571.
19. Hughes AJ, Herr AE (2010) Quantitative enzyme activity determination with zeptomole sensitivity by microfluidic gradient-gel zymography. Anal Chem 82:3803-3811.
20. Holmes DL, Stellwagen NC (1991) Estimation of polyacrylamide gel pore size from Ferguson plots of linear DNA fragments II. Comparison of gels with different cross-linker concentrations, added agarose and added linear polyacrylamide. Electrophoresis 12:612-619.
21. Matta A, et al. (2004) Computational study of band-crossing reactions. J Microelectromech Syst 13:310-322.
22. Dorman G, Prestwich GD (1994) Benzophenone photophores in biochemistry. Biochemistry 33:5661-5673. (Pubitemid 24184566)
23. Righetti PG (1983) Isoelectric Focusing: Theory, Methodology and Applications (Elsevier, New York).
24. Sommer GJ, Singh AK, Hatch AV (2008) On-chip isoelectric focusing using photopolymerized immobilized pH gradients. Anal Chem 80:3327-3333. (Pubitemid 351620718)
25. Squires TM, Messinger RJ, Manalis SR (2008) Making it stick: Convection, reaction and diffusion in surface-based biosensors. Nat Biotechnol 26:417-426. (Pubitemid 351501812)
26. Gianazza E, Righetti PG (1980) Size and charge distribution of macromolecules in living systems. J Chromatogr 193:1-8.
27. Craig DB, Wetzl BK, Duerkop A, Wolfbeis OS (2005) Determination of picomolar concentrations of proteins using novel amino reactive chameleon labels and capillary electrophoresis laser-induced fluorescence detection. Electrophoresis 26:2208-2213. (Pubitemid 40852653)
28. Righetti PG, Simo C, Sebastiano R, Citterio A (2007) Carrier ampholytes for IEF, on their fortieth anniversary (1967-2007), brought to trial in court: The verdict. Electrophoresis 28:3799-3810. (Pubitemid 350143116)
29. Donohue MJ, et al. (2005) Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity. Anal Biochem 339:318-327. (Pubitemid 40395290)
30. Vaisanen V, et al. (1999) Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells. Prostate Cancer Prostatic Dis 2:91-97. (Pubitemid 29259939)